Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1

被引:63
作者
Morrison, LA [1 ]
Knipe, DM [1 ]
机构
[1] HARVARD UNIV,SCH MED,DEPT MICROBIOL & MOLEC GENET,BOSTON,MA 02115
关键词
D O I
10.1006/viro.1996.0328
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have investigated the mechanisms by which subcutaneous immunization of mice with a replication-defective mutant of herpes simplex virus 1 protects against infection of the eye and latent infection of the trigeminal ganglion following corneal challenge. First, we have shown that immunization reduces the number of trigeminal ganglion neurons in challenged animals that express the latency-associated transcript. This indicates that the reduction in the incidence of latent infection by challenge virus is likely due to immune mechanisms and not saturation of the potential sites of latent infection by the immunizing mutant virus itself. Second, the duration of protective immunity against acute infection, keratitis, and latent infection was similar in mice immunized with replication-defective or -competent virus; thus, the replication-defective mutant virus is able to induce durable immunity apparently without spread in the host. Third, although the mutant virus showed no evidence of replication in vivo, it was present in footpad tissue in an infectious form for several days. This surprising observation raises the possibility that continued infection events by input virus over an extended period of time may have a boosting effect on the developing immune response which could explain, at least in part, the capacity of these replication-defective mutant viruses to elicit a robust and durable immunity despite their inability to spread within the host. (C) 1996 Academic Press, Inc.
引用
收藏
页码:402 / 413
页数:12
相关论文
共 60 条
[31]   A RECOMBINANT GLYCOPROTEIN VACCINE FOR HERPES-SIMPLEX TYPE-2 - SAFETY AND EFFICACY [J].
LANGENBERG, AGM ;
BURKE, RL ;
ADAIR, SF ;
SEKULOVICH, O ;
TIGGES, M ;
DEKKER, CL ;
COREY, L .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (12) :889-898
[32]   A DELETION MUTANT OF THE LATENCY-ASSOCIATED TRANSCRIPT OF HERPES-SIMPLEX VIRUS TYPE-1 REACTIVATES FROM THE LATENT STATE WITH REDUCED FREQUENCY [J].
LEIB, DA ;
BOGARD, CL ;
KOSZVNENCHAK, M ;
HICKS, KA ;
COEN, DM ;
KNIPE, DM ;
SCHAFFER, PA .
JOURNAL OF VIROLOGY, 1989, 63 (07) :2893-2900
[33]   THE PROMOTER OF THE LATENCY-ASSOCIATED TRANSCRIPTS OF HERPES-SIMPLEX VIRUS TYPE-1 CONTAINS A FUNCTIONAL CAMP-RESPONSE ELEMENT - ROLE OF THE LATENCY-ASSOCIATED TRANSCRIPTS AND CAMP IN REACTIVATION OF VIRAL LATENCY [J].
LEIB, DA ;
NADEAU, KC ;
RUNDLE, SA ;
SCHAFFER, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (01) :48-52
[34]   EXPERIMENTAL KERATITIS IN RABBITS BY HUMAN HSV-1 VARIANTS - PREVENTION AND TREATMENT [J].
MANSERVIGI, R ;
INCORVAIA, C ;
DILUCA, D ;
ROTOLA, A ;
BALBONI, PG ;
SEBASTIANI, A ;
ROSSI, A ;
CASSAI, E .
JOURNAL OF MEDICAL VIROLOGY, 1990, 32 (03) :148-154
[35]   PROTECTION FROM HERPES-SIMPLEX VIRUS TYPE-1 LETHAL AND LATENT INFECTIONS BY SECRETED RECOMBINANT GLYCOPROTEIN-B CONSTITUTIVELY EXPRESSED IN HUMAN-CELLS WITH A BK VIRUS EPISOMAL VECTOR [J].
MANSERVIGI, R ;
GROSSI, MP ;
GUALANDRI, R ;
BALBONI, PG ;
MARCHINI, A ;
ROTOLA, A ;
RIMESSI, P ;
DILUCA, D ;
CASSAI, E ;
BARBANTIBRODANO, G .
JOURNAL OF VIROLOGY, 1990, 64 (01) :431-436
[36]   PROTECTIVE VACCINATION AGAINST PRIMARY AND RECURRENT DISEASE CAUSED BY HERPES-SIMPLEX VIRUS (HSV) TYPE-2 USING A GENETICALLY DISABLED HSV-1 [J].
MCLEAN, CS ;
ERTURK, M ;
JENNINGS, R ;
NICHALLANAIN, D ;
MINSON, AC ;
DUNCAN, I ;
BOURSNELL, MEG ;
INGLIS, SC .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) :1100-1109
[37]   IN-SITU DNA PCR AND RNA HYBRIDIZATION DETECTION OF HERPES-SIMPLEX VIRUS SEQUENCES IN TRIGEMINAL GANGLIA OF LATENTLY INFECTED MICE [J].
MEHTA, A ;
MAGGIONCALDA, J ;
BAGASRA, O ;
THIKKAVARAPU, S ;
SAIKUMARI, P ;
VALYINAGY, T ;
FRASER, NW ;
BLOCK, TM .
VIROLOGY, 1995, 206 (01) :633-640
[38]  
MELGNIER B, 1987, J INFECT DIS, V155, P921
[39]   HERPES-SIMPLEX VIRUS TYPE-2 GLYCOPROTEIN-SUBUNIT VACCINE - TOLERANCE AND HUMORAL AND CELLULAR-RESPONSES IN HUMANS [J].
MERTZ, GJ ;
PETERMAN, G ;
ASHLEY, R ;
JOURDEN, JL ;
SALTER, D ;
MORRISON, L ;
MCLEAN, A ;
COREY, L .
JOURNAL OF INFECTIOUS DISEASES, 1984, 150 (02) :242-249
[40]   DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF A HERPES-SIMPLEX VIRUS TYPE-2 GLYCOPROTEIN VACCINE IN PERSONS AT HIGH-RISK FOR GENITAL HERPES INFECTION [J].
MERTZ, GJ ;
ASHLEY, R ;
BURKE, RL ;
BENEDETTI, J ;
CRITCHLOW, C ;
JONES, CC ;
COREY, L .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04) :653-660